# Docusate/Senna for the Treatment of Diabetic Gastroparesis

> **NCT03342157** · PHASE2 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 2 (actual)

## Conditions studied

- Diabetic Gastroparesis

## Interventions

- **DRUG:** senna/docusate

## Key facts

- **NCT ID:** NCT03342157
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-02
- **Primary completion:** 2018-08-17
- **Final completion:** 2018-08-17
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2024-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03342157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03342157, "Docusate/Senna for the Treatment of Diabetic Gastroparesis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03342157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*